I can claim things are going better than expected because the clinical trial are going well since IMU received Fast track designation and ODD as the FDA has data demonstrating not only safety but efficacy, hence why I replied that was my focus. Did you expect to them to achieve these so quickly since now you know what's the primary endpoint of Ph1 clinical trial is about safety, even LC said this when the Ph1 clinical trial started for VAXINIA.
IMU Price at posting:
3.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)